States / Virginia / SB 641

SB 641 Enacted

Office-based buprenorphine treatment; Board of Medicine to amend regulations.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Apr 6, 2026 · Office of the Governor
Acts of Assembly Chapter text (CHAP0208)
Apr 6, 2026 · Office of the Governor
Approved by Governor-Chapter 208 (effective 7/1/2026)
Mar 10, 2026 · Senate
Enrolled Bill communicated to Governor on March 10, 2026
Mar 10, 2026 · Office of the Governor
Governor's Action Deadline 11:59 p.m., April 13, 2026
Mar 2, 2026 · Senate
Fiscal Impact statement From DPB (3/2/2026 2:20 pm)
Feb 26, 2026 · Senate
Enrolled
Feb 26, 2026 · Senate
Bill text as passed Senate and House (SB641ER)
Feb 26, 2026 · House
Signed by Speaker
Feb 26, 2026 · Senate
Signed by President
Feb 24, 2026 · House
Read third time
Feb 24, 2026 · House
Passed House (98-Y 0-N 0-A)
Feb 23, 2026 · House
Read second time
Feb 19, 2026 · House
Reported from Health and Human Services (21-Y 0-N)
Feb 13, 2026 · House
Placed on Calendar
Feb 13, 2026 · House
Read first time
Feb 13, 2026 · House
Referred to Committee on Health and Human Services
Feb 10, 2026 · Senate
Read third time and passed Senate (40-Y 0-N 0-A)
Feb 9, 2026 · Senate
Read second time
Feb 9, 2026 · Senate
Engrossed by Senate (Voice Vote)
Feb 6, 2026 · Senate
Rules suspended
Feb 6, 2026 · Senate
Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A)
Feb 6, 2026 · Senate
Passed by for the day (Voice Vote)
Feb 6, 2026 · Senate
Passed by for the day
Feb 5, 2026 · Senate
Reported from Education and Health (14-Y 0-N)
Jan 30, 2026 · Senate
Assigned Education sub: Health Professions
Jan 21, 2026 · Senate
Fiscal Impact Statement from Department of Planning and Budget (SB641)
Jan 14, 2026 · Senate
Prefiled and ordered printed; Offered 01-14-2026 26104754D
Jan 14, 2026 · Senate
Referred to Committee on Education and Health